Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
2.040
+0.120 (6.25%)
At close: Oct 6, 2025, 4:00 PM EDT
2.000
-0.040 (-1.96%)
Pre-market: Oct 7, 2025, 4:47 AM EDT
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $19.75 million as of October 6, 2025. Its market cap has decreased by -45.33% in one year.
Market Cap
19.75M
Enterprise Value
22.89M
1-Year Change
-45.33%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $19.75M, a decrease of -70.23%. That is a compound annual growth rate of -15.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 19.75M | -32.86% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | 471.81M | 1,336.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |